- Report
- September 2026
- 185 Pages
Global
From €3221EUR$3,545USD£2,769GBP
€3579EUR$3,939USD£3,077GBP
- Report
- February 2026
- 250 Pages
Global
From €4080EUR$4,490USD£3,507GBP
- Report
- September 2026
- 158 Pages
Global
From €4952EUR$5,450USD£4,257GBP
- Report
- August 2026
- 120 Pages
Global
From €4316EUR$4,750USD£3,710GBP
- Report
- January 2026
- 160 Pages
Global
From €2871EUR$3,160USD£2,468GBP
€3589EUR$3,950USD£3,085GBP
- Report
- November 2025
- 150 Pages
Global
From €5406EUR$5,950USD£4,648GBP
- Report
- September 2026
- 606 Pages
Global
From €6356EUR$6,995USD£5,464GBP
- Report
- January 2026
- 120 Pages
Global
From €5406EUR$5,950USD£4,648GBP
- Report
- September 2026
- 194 Pages
Global
From €3221EUR$3,545USD£2,769GBP
€3579EUR$3,939USD£3,077GBP
- Report
- September 2026
- 199 Pages
Global
From €3221EUR$3,545USD£2,769GBP
€3579EUR$3,939USD£3,077GBP
- Report
- August 2026
- 171 Pages
Global
From €3589EUR$3,950USD£3,085GBP
- Report
- February 2026
- 94 Pages
Global
From €3500EUR$4,126USD£3,114GBP
- Report
- June 2026
- 200 Pages
Europe
From €2717EUR$2,990USD£2,335GBP
- Report
- April 2026
- 80 Pages
United States
From €5406EUR$5,950USD£4,648GBP
- Report
- September 2023
- 90 Pages
Global
From €5406EUR$5,950USD£4,648GBP
- Report
- November 2023
Global
From €2249EUR$2,475USD£1,933GBP
€4498EUR$4,950USD£3,866GBP
- Report
- August 2025
- 180 Pages
Global
From €4089EUR$4,500USD£3,515GBP
- Report
- May 2024
- 200 Pages
Global
From €3771EUR$4,150USD£3,242GBP
- Report
- August 2024
- 150 Pages
Global
From €3407EUR$3,750USD£2,929GBP
- Report
- September 2022
- 417 Pages
Global
From €3271EUR$3,600USD£2,812GBP

The Respiratory Disease Test market within the context of Diagnostics is a rapidly growing sector, as respiratory diseases are among the most common illnesses worldwide. Tests for respiratory diseases are used to diagnose and monitor a variety of conditions, including asthma, chronic obstructive pulmonary disease (COPD), and pneumonia. These tests can be conducted in a variety of ways, including imaging tests, pulmonary function tests, and laboratory tests. Imaging tests such as X-rays and CT scans are used to detect abnormalities in the lungs, while pulmonary function tests measure the amount of air a person can inhale and exhale. Laboratory tests, such as sputum tests, are used to detect the presence of bacteria or viruses in the lungs.
Some companies in the Respiratory Disease Test market include Abbott Laboratories, Becton Dickinson, Siemens Healthineers, Roche Diagnostics, and Thermo Fisher Scientific. Show Less Read more